Research is being conducted on the role of cancer-associated fibroblasts in cancer drug resistance and progression. Studies have investigated the mechanisms by which these fibroblasts contribute to resistance in various types of cancer, including lung, breast, and colorectal cancer. The findings suggest that cancer-associated fibroblasts may play a significant role in promoting treatment resistance and could potentially be targeted for therapeutic purposes.